In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they should market their platform to others, or leverage it ...
The quest for healthier, safer, and affordable dietary options and enhanced nutritional content and quality has spurred ...
What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...
Press Release Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led by GV, with ...
The outlook for life sciences IPOs is showing renewed optimism heading into 2025, with market conditions becoming more constructive and ...
This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends ...
Hosted on MSN1d
Understanding the Difference Between Proofreading & Editing (And Where to Find the Work)I’ve been a writer since, technically, the third grade, when my short story, The Wolf & I, won me third place and $300 i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback